Shivalik Rasayan Limited has informed the Exchange regarding Board meeting held on August 12, 2025.
SHIVALIK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shivalik Rasayan reported strong revenue growth for Q1 FY26 (quarter ended June 30, 2025) but a sharp drop in profits. Standalone net sales rose to Rs. 4,626.45 lakhs from Rs. 3,158.11 lakhs in Q1 FY25, a jump of about 46.5%. However, standalone net profit fell to Rs. 122.08 lakhs from Rs. 306.92 lakhs a year ago, with EPS slipping to Rs. 0.78 from Rs. 1.97. The Agrochemicals segment led revenue (Rs. 4,433.88 lakhs) while the API segment continued to post losses of Rs. (295.95) lakhs. On a consolidated basis, net sales grew to Rs. 8,930.93 lakhs with net profit of Rs. 282.13 lakhs. The Board also approved a draft final dividend of Rs. 0.50 per share (10%) for FY25, subject to shareholder approval at the 47th AGM on September 27, 2025, and cleared the incorporation of a wholly owned subsidiary for pesticide formulations manufacturing.
Mixed for shareholders: healthy top-line growth signals business expansion, but the sharp YoY fall in net profit and continued API segment losses may pressure the stock in the short term. The new subsidiary for forward integration into pesticide formulations and the proposed dividend are positives for long-term investors.